Plasma and rectal adenosine in inflammatory bowel disease: Effect of methotrexate

Inflammatory Bowel Diseases

Volumn 5, Issue 3, 1999, Pages 167-173

  Egan, Laurence J ^a   Sandborn, William J ^a   Mays, Dennis C ^a   Tremaine, William J ^a   Lipsky, James J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adenosine; Inflammatory bowel disease; Methotrexate; Rectum

Indexed keywords

ADENOSINE; ANTIINFLAMMATORY AGENT; METHOTREXATE;

ADULT; AGED; ARTICLE; BLOOD; DIALYSIS; ENTERITIS; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; RECTUM;

ADENOSINE; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; DIALYSIS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; METHOTREXATE; MIDDLE AGED; RECTUM; STATISTICS, NONPARAMETRIC;

EID: 0033175866     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199908000-00004     Document Type: Article

References (4)

1. Feagan BG, Rochon J, Fedorak RN, et al. Melhotrexate for the treatment of Crohn's disease. N Engl J Med 1995;332:292-7.
2. Weinstein GD, Jeffes E, McCullough JL. Cytotoxic and immuno-logic effects of methotrexate in psoriasis. J Invest Derinatol 1990;95:49S-52S.
3. Olsen NJ, Murray LM. Antiproliferative effects of methotrexate on peripheral blood mononuclear cells. Arthritis Rheum 1989;32:378-85.
4. Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intent Med 1994;121:833-41.